Yann Mazabraud
Corporate Officer/Principal en RHYTHM PHARMACEUTICALS, INC. .
Fortuna: 1 M $ al 30/04/2024
Perfil
Yann Mazabraud currently works at Rhythm Pharmaceuticals, Inc., as Executive Vice President & Head-International from 2020.
Mr. Mazabraud also formerly worked at Genzyme Corp., as General Manager-US & Head-North America from 2016 to 2017, Genzyme Therapeutics Ltd., as Head-Latin America, and Trevi Therapeutics, Inc., as Chief Commercial Officer & Head-International from 2017 to 2020.
Mr. Mazabraud received his graduate degree from Groupe de Sup de Co La Rochelle.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 22/04/2024 | 34 870 ( 0.06% ) | 1 M $ | 30/04/2024 |
Cargos activos de Yann Mazabraud
| Empresas | Cargo | Inicio |
|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 05/10/2020 |
Antiguos cargos conocidos de Yann Mazabraud.
| Empresas | Cargo | Fin |
|---|---|---|
| TREVI THERAPEUTICS, INC. | Corporate Officer/Principal | 03/10/2020 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/10/2017 |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Corporate Officer/Principal | - |
Formación de Yann Mazabraud.
| Groupe de Sup de Co La Rochelle | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| TREVI THERAPEUTICS, INC. | Health Technology |
| RHYTHM PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Yann Mazabraud